IBCSG 60-19 APPALACHES

  • This is a two-arm open-label multi-center randomized (2:1) non-comparative phase II study in elderly patients with stage II/III, ER+, HER2- early breast cancer for whom treatment with chemotherapy is indicated.

    • Trial Coordinator
      Meredith Kissel

      IBCSG Data Management Center/Frontier Science Foundation
      4033 Maple Road
      Amherst, New York 14226 USA
      Phone: +1 716 834 0900
      Fax: +1 716 833 3990
      Email:
      This email address is being protected from spambots. You need JavaScript enabled to view it.

       

      Targeted Accrual
      366

      Enrollment closure date
      September 22, 2022

    ETOP IBCSG Partners Foundation
    Effingerstrasse 33
    3008 Bern, Switzerland

    Contact
    Phone: +41 31 511 94 00
    E-mail: contact@etop.ibcsg.org

    Member Login